Kenshiro Takemoto

The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy

Kenshiro Takemoto, Jun Teishima, Yuki Kohada et al. · Anticancer Research · 2020 · 17 citations · Full text

Clinicopathological significance of the overexpression of MUC1 in upper tract urothelial carcinoma and possible application as a diagnostic marker

Go Kobayashi, Tetsutaro Hayashi, Kazuhiro Sentani et al. · Pathology International · 2022 · 17 citations

Clinicopathological Significance, Urology, Tumoral Pathology +15

<scp>BACH1</scp> promotes clear cell renal cell carcinoma progression by upregulating oxidative stress‐related tumorigenicity

Kenshiro Takemoto, Kohei Kobatake, Kento Miura et al. · Cancer Science · 2022 · 16 citations · Full text

Renal Pathology, Renal Inflammation, Pathology +18

CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma

Yohei Sekino, Kenshiro Takemoto, Daiki Murata et al. · Anticancer Research · 2021 · 12 citations · Full text

Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomy

Kenshiro Takemoto, Tetsutaro Hayashi, Ryan S. Hsi et al. · Urologic Oncology Seminars and Original Investigations · 2022 · 11 citations

Urology, Surgical Oncology, Tumoral Pathology +10